Rina Chin, Eli Lilly Japan, Tokyo, Japan, and colleagues, therefore, aimed to assess the safety and glycaemic efficacy of tirzepatide as an add-on treatment in Japanese patients with type 2 diabetes who had inadequate glycaemic control with stable doses of various oral antihyperglycaemic monotherapies in a multicentre, open-label, parallel-group, randomized, phase 3 trial
For those taking Wegovy, adhering to a reduced-calorie diet is essential
Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis
De speciale maagresistente capsule zorg ervoor dat Acetyl-L-Glutathion moeiteloos het maag-darm kanaal bereikt.
A thiol-specific fluorescent probe and its application for bioimaging